Page last updated: 2024-08-24

triazoles and itraconazole

triazoles has been researched along with itraconazole in 638 studies

Research

Studies (638)

TimeframeStudies, this research(%)All Research%
pre-199031 (4.86)18.7374
1990's59 (9.25)18.2507
2000's217 (34.01)29.6817
2010's280 (43.89)24.3611
2020's51 (7.99)2.80

Authors

AuthorsStudies
Andrade, J; Armstrong, D; Edwards, F; Niki, Y; Schmitt, HJ1
Bava, AJ; Negroni, R1
Graybill, JR; Sharkey, PK1
Hector, RF; Yee, E1
Defaveri, J; Graybill, JR; Sun, SH1
Defaveri, J; Graybill, JR1
Perfect, JR; Ritter, W; Wright, KA1
Dupont, B1
Mattie, H; van Furth, R; Van t Wout, JW1
Kobayashi, GS; Spitzer, ED1
Graybill, JR1
Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D1
Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F1
Polak, A1
Dismukes, WE; Saag, MS1
Walsh, TJ1
Dismukes, WE1
Coulaud, JP; Ngo Van, P1
Pizzo, A; Walsh, TJ1
Gordon, MA; Lapa, EW; Passero, PG1
Beach, DH; Goad, LJ; Holz, GG1
Faergemann, J1
Hay, RJ2
Stevens, DA1
Bennett, JE; Kan, VL1
Ackerbauer, H; Meingassner, JG; Mieth, H1
Durack, DT; Perfect, JR1
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC1
Durack, DT; Perfect, JR; Savani, DV1
Cauwenbergh, G1
Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW1
Abruzzo, GK; Bulmer, GS; Fromtling, RA1
Meingassner, JG; Schaude, M1
Cobo, LM; Durack, DT; Perfect, JR; Savani, DV1
Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA1
Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S1
Abbott, AB; Odds, FC; Webster, CE1
Backx, LJ; Heeres, J; Van Cutsem, J1
Denning, DW; Hall, L; Hollis, S; Jackson, M1
Allendoerfer, R; Graybill, JR; Loebenberg, D; Rinaldi, MG1
Clemons, KV; Homola, ME; Stevens, DA1
Benveniste, P; Chaubet, N; Gigot, C; Grausem, B; Loper, JC1
Denning, DW; Law, D; Mason, C; Moore, CB; Wardle, HM1
Bale, MJ; Buschelman, B; Pfaller, MA; Rhomberg, P1
Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW1
Denning, DW; Law, D; Moore, CB2
Bastide, JM; Janbon, F; Le Guennec, R; Mallié, M; Pujol, C; Reynes, J1
Cox, GM; Dodge, RK; Perfect, JR; Schell, WA1
Chanock, SJ; Walsh, TJ1
Hitchcock, CA; Martin, MV; Yates, J1
Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A1
Galgiani, JN; Lewis, ML1
Jones, RN; Messer, S; Pfaller, MA1
Armstrong, D; Bernard, EM; Ishimaru, T; Murphy, M1
Johnson, EM; Radford, SA; Warnock, DW1
Denning, DW; Moore, CB; Oakley, KL2
Hollis, RJ; Pfaller, MA; Zhang, J1
Carver, PL; Kauffman, CA1
Denning, DW; Morrissey, G; Oakley, KL1
Aristizabal, BH; Clemons, KV; Lutz, JE; Stevens, DA1
Denning, DW; Kelly, SL; Venkateswarlu, K1
Hernanz Hermosa, JM; Lázaro Ochaita, P1
Jones, RN; Marco, F; Messer, S; Pfaller, MA1
Gubbins, PO; Penzak, SR1
Nguyen, MH; Yu, CY2
Kauffman, CA; Zarins, LT2
McGinnis, MR; Pasarell, L1
Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA2
Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA1
Denning, DW; Donnelly, JP; Meis, JF; Mensink, M; Rijs, AJ; Verweij, PE1
Chandrasekar, PH; Cutright, JL; Manavathu, EK2
Cuenca-Estrella, M; Martínez-Suárez, JV; Mellado, E; Monzón, A; Rodríguez-Tudela, JL1
Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J1
Brizendine, E; Connolly, P; Durkin, M; Goldberg, J; Kohler, S; Loebenberg, D; Schnizlein-Bick, C; Smedema, M; Wheat, J1
Chandrasekar, PH; Cutright, J; Manavathu, EK1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ1
Abraham, OC; Chandrasekar, PH; Cutright, JL; Manavathu, EK1
Johnson, EM; Szekely, A; Warnock, DW1
Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I1
Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL1
Diekema, DJ; Doern, GV; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA1
Cuenca-Estrella, M; Monzón, A; Ramos, G; Rodríguez-Tudela, JL1
Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH1
Bonner, DP; Fung-Tomc, JC; Huczko, E; Minassian, B; White, TC1
Denning, DW; Moore, CB; Walls, CM1
Fothergill, AW; Kirkpatrick, WR; Loebenberg, D; McAtee, RK; Patterson, TF; Rinaldi, MG1
Al-Abdely, HM; Bocanegra, R; Fothergill, A; Graybill, JR; Loebenberg, D; Najvar, L; Rinaldi, MG1
Ciblak, MA; Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW1
Niki, Y1
Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK1
Arzeni, D; Barchiesi, F; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Fallani, S; Fortuna, M; Giacometti, A; Giannini, D; Mazzei, T; Novelli, A; Scalise, G; Schimizzi, AM1
Brizendine, E; Connolly, P; Durkin, M; Goldberg, J; Kohler, S; Loebenberg, D; Schnizlein-Bick, C; Smedema, M; Wheat, LJ1
Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T1
Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM1
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O1
Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B1
Dierich, MP; Lass-Flörl, C; Nagl, M; Speth, C; Ulmer, H; Würzner, R1
Avila, N; Bacher, J; Candelario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, S; Sein, T; Walsh, TJ1
Espinel-Ingroff, A1
Chen, L; Srinivas, NR; Yao, M1
Leitner, I; Ryder, NS1
Kämmerer, R; Klempien, I; Kujath, P; Muhl, E1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ1
Abraham, OC; Chandrasekar, PH; Manavathu, EK1
Boyle, K; Espinel-Ingroff, A; Sheehan, DJ1
Crego, AL; Gómez, J; Lavandera, JL; Marina, ML1
Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW1
Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Arzeni, D; Barchiesi, F; Camiletti, V; Cellini, A; Offidani, AM; Scalise, G; Simonetti, O1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A1
Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL1
Fukuoka, T; Harada, Y; Harasaki, T; Inoue, S; Kamai, Y; Konosu, T; Mori, M; Nakagawa, A; Nakamura, Y; Ohya, S; Oida, S; Seki, S; Seta, Y; Shibayama, T; Somada, A; Uchida, T; Yasuda, H1
Denning, DW; Mosquera, J1
Arzeni, D; Barchiesi, F; D'Angelo, M; Falconi Di Francesco, L; Giuliana, G; Milici, ME; Pizzo, G; Scalise, G1
Calderon, L; Clemons, KV; Martinez, M; Stevens, DA1
De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H1
Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA1
Ellepola, AN; Samaranayake, LP1
Gil-Lamaignere, C; Maloukou, A; Mosquera, J; Roilides, E; Walsh, TJ1
De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE1
Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA1
Ichihara, S; Murasaki, C; Ohwada, J; Shimma, N; Umeda, I; Yamazaki, T1
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C1
Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A1
Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, JB; Pfaller, MA1
Bruneau, JM; Caer, JP; Fudali, C; Hodgson, J; Labas, V; Lecaque, D; Legrand, R; Maillet, I; Supatto, F; Tagat, E1
Dierch, MP; Gunsilius, E; Kofler, G; Lass-Flörl, C; Speth, C; Würzner, R1
Kamei, K1
Lipp, HP2
Matysiak, J; Niewiadomy, A1
Hamza, SH; Mercado, PJ; Skelton, HG; Smith, KJ1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL2
del Palacio, A; Garau, M; Pereiro, M1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL2
Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A1
Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N1
Chaturvedi, V; Gangwar, M; Ramani, R1
Dannaoui, E; Loebenberg, D; Meis, JF; Verweij, PE1
Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S1
Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM1
Ausma, J; Borgers, M; Heeres, J; Meerpoel, L; Odds, F; Van Gerven, F; Vanden Bossche, H; Woestenborghs, F1
Maertens, JA1
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I1
Schwartz, S; Thiel, E1
Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M1
Ausma, J; Bohets, H; Borgers, M; Marichal, P; Meerpoel, L; Odds, F; Vanden Bossche, H; Vermuyten, K; Willemsens, G1
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE1
Gavaldá, J; Lumbreras, C1
Wark, P1
Jones, AL; Pai, MP1
Balajee, SA; Gribskov, JL; Imhof, A; Marr, KA1
Cariani, L; Drago, M; Morace, G; Scaltrito, MM1
Alexander, BD; Brennan, K; Forrest, G; Husain, S; Muñoz, P; Singh, N; Somani, J; Wagener, MM1
Han, XY; Hassan, SA; Matsuda, SP; May, GS; Tarrand, JJ; Wilson, WK; Xiong, Q1
Adelson, ME; Mordechai, E; Trama, JP1
García-Agudo, L; García-Martos, P; Gutiérrez-Calzada, J; Marín, P; Ruiz-Aragón, J; Saldarreaga, A1
Klepser, ME; Lewis, RE; Wiederhold, NP1
Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL1
Ausma, J; Backx, LJ; Borgers, M; Corens, D; De Groot, A; Heeres, J; Marichal, PJ; Meerpoel, L; Odds, FC; Oris, M; Van Breda, A; Van der Veken, LJ; van Dorsselaer, P; Van Gerven, F; Vanden Bossche, HF; Vermuyten, KJ; Willemsens, GH; Woestenborghs, FA1
Bastide, JM; Blancard, A; Bonnin, A; Bretagne, S; Cambon, M; Chandenier, J; Chauveau, V; Couprie, B; Datry, A; Feuilhade, M; Grillot, R; Guiguen, C; Lavarde, V; Letscher, V; Linas, MD; Mallié, M; Michel, A; Morin, O; Paugam, A; Piens, MA; Raberin, H; Tissot, E; Toubas, D; Wade, A1
Yasuda, MA1
Nolard, N; Swinne, D; Watelle, M1
Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H1
Batra, R; Gupta, AK; Kohli, Y1
Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P1
Böhme, A; Haas, A; Maschmeyer, G1
Steinbach, WJ1
Chen, R; Liao, W; Yao, Z1
Fruehwirth, F; Khoschsorur, G; Zelzer, S1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J1
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE1
Jagirdar, J; Scott, RS; Sutton, DA1
Cetinkaya, Z; Kiraz, N1
Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V1
Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG1
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE1
Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG1
Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP1
Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM1
Bishara, J; Peled, N; Samra, Z; Yardeni, M1
Niwa, T; Shiraga, T; Takagi, A1
Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T1
Colombo, GL; Morlotti, L; Serra, G1
Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR1
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G1
Alvarado, P; de Albornoz, MC; Díaz de Torres, E; Lucena, L; Mendoza, M1
Cutler, JE; Hazen, KC; Wetter, TJ1
Araujo, R; Pina-Vaz, C; Rodrigues, AG2
Alcalá, L; Bouza, E; Guinea, J; Peláez, T3
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F1
Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL1
Denning, DW; Dupont, B; Lode, H; Sambatakou, H1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Chaturvedi, V; Cole, R; Gangwar, M; Ramani, R; Sheehan, DJ1
Bailey, TA; Di Somma, A; Silvanose, CD1
Cepero de García, MC; Espinel-Ingroff, A; Rincón, S1
Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I1
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA1
Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A1
Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS1
Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D1
Hutzler, JM; Locuson, CW; Tracy, TS1
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ1
De Pauw, BE; Donnelly, JP1
Bandrés Gimeno, R; Muñoz Martínez, MJ1
Maesaki, S2
da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J1
Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R1
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G1
Sellart-Altisent, M; Torres-Rodríguez, JM1
Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN1
James, C; Moore, MH; Murphy, D1
Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A1
Alvarado-Ramírez, E; Torres-Rodríguez, JM1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C1
Gupta, A; Mao, Q; Unadkat, JD1
Germaud, P; Pipet, A1
Bellmann, R; Weiler, S1
van Dissel, JT; van Nieuwkoop, C1
Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M1
Chen, SC; Sorrell, TC1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF1
Kaya, AD; Kiraz, N1
Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y1
Espinel-Ingroff, A; Goldani, LZ; Goodrich, JM; Queiroz-Telles, F; Schlamm, HT; Shikanai-Yasuda, MA1
Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W1
Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A1
Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW1
Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM1
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P1
Andrew, S; Fitzgerald, D; Singh, MN1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Troke, P1
Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ1
Almeida, C; Martín-Mazuelos, E; Méndez, CC; Pemán, J; Serrano, MC; Valverde, A1
Ali, S; Whittle, AM1
Ergon, C; Metin, DY; Ozkutuk, A; Polat, SH; Yucesoy, M1
Andes, D; Smith, J1
Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M1
Ishida, S; Matsui, H; Nishimura, Y; Okano, Y; Oyama, TB; Oyama, TM; Oyama, Y; Sakanashi, Y; Yokota, S1
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Ooi, WW; Srinivasan, J1
Karthaus, M2
Ayala, J; Elizondo, M; González, GM1
Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S1
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A1
Hollenbach, E1
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P1
Anderson, R; Steel, HC; Tintinger, GR1
Kagoshima, Y; Konosu, T; Oida, S; Somada, A; Uchida, T1
Brown, TA; Grooters, AM; Hosgood, GL1
Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE1
Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE1
Collins, CD; Ellis, JJ; Kaul, DR1
Bearman, G; Pakyz, A1
Maesaki, S; Tarumoto, N1
Fujii, Y; Inase, N; Yoshizawa, Y1
dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I1
Fothergill, AW; Rinaldi, MG; Sutton, DA1
de Mol, P; Meis, JF1
Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L1
Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B1
Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Ben-Ami, R; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE; Samonis, G1
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R1
Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T1
Dannaoui, E; Lortholary, O; Schwarz, P1
Bulut, Y; Günday, E; Güven, M; Yenişehirli, G1
Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S1
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL1
Li, R; Liu, W; Wan, Z; Wang, X; Yang, J1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S1
Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S1
Alp, S; Arikan, S; Hasçelik, G; Sancak, B1
Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS1
Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF1
Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB1
Denning, DW; Howard, SJ; Pasqualotto, AC1
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G1
Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A1
Black, TA; Chau, AS; Cornely, OA; Mann, PA; McNicholas, PM; Mendrick, C; Patel, R; Patino, H; Ullmann, AJ1
Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B1
Al-Abdely, HM; Al-Tawfiq, JA1
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L1
Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W1
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ1
Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M1
Park, S; Perlin, DS; Procop, GW; Reja, V; Tuohy, MJ; Wnek, M; Yen-Lieberman, B1
Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F1
Vera-Cabrera, L; Welsh, E; Welsh, O1
Crespo-Erchiga, V; Gómez-Moyano, E; Hiraldo-Gamero, A; Segura-Palacios, JM1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA1
Calvo, E; Guarro, J; Pastor, FJ1
Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G1
Kondori, N; Mattsby-Baltzer, I; Svensson, E1
Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H1
Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J1
Lazzaro, C1
Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG1
Heeres, J; Lewi, P; Meerpoel, L1
Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG1
Alvarez, E; Cano, J; Fothergill, AW; Guarro, J; Rinaldi, MG; Salas, V; Stchigel, AM; Sutton, DA1
Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L1
Cleveland, KO; Mazumder, SA; Norwood, J1
Arnan, M; Duarte, RF; Encuentra, M; Fernández de Sevilla, A; Gudiol, C; Parody, R; Patiño, B; Peralta, T; Sánchez-Ortega, I1
Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M1
Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG1
Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA1
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA1
Cos, P; de Wit, K; Maes, L; Matheeussen, A; Paulussen, C; van Rossem, K1
Arendrup, MC; Johansen, HK; Lass-Flörl, C; Mellado, E; Mortensen, KL; Rodriguez-Tudela, JL1
Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B1
Alvarez, E; Cano, JF; Dromer, F; Fothergill, AW; Garcia-Hermoso, D; Guarro, J; Hoinard, D; Rinaldi, MG; Stchigel, AM; Sutton, DA1
Dranitsaris, G; Khoury, H1
Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X1
Fujiya, M; Hosoki, T; Ikuta, K; Kohgo, Y; Okamura, N; Sato, K; Torimoto, Y; Yamamoto, M1
Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E1
Ko, KS; Lee, JY; Peck, KR; Song, JH1
Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S1
Fahal, AH; van Belkum, A; van de Sande, WW1
Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S1
Pena, TA; Samavati, L; Soubani, AO1
Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V1
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR1
Nweze, EI; Ogbonnaya, UL1
Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL1
Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ1
Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG1
Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA1
Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S1
George, J; Reboli, AC1
Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M1
Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ1
Biancalana, FS; Lyra, L; Schreiber, AZ1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY1
Cortopassi, WA; França, TC; Krettli, AU; Oliveira, AA; Penna-Coutinho, J1
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K1
Berbel, RF; Casella, AM; de Freitas, D; Höfling-Lima, AL1
Alves, SH; Azevedo, MI; Rossato, L; Santurio, JM; Spader, TB; Tronco-Alves, GR; Venturini, TP; Weiler, CB1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA1
Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C1
Beguin, H; Detandt, M; Hendrickx, M1
Al Abdallah, Q; Campoli, P; Fielhaber, JA; Filler, SG; Kristof, AS; Laverdiere, M; Robitaille, R; Sheppard, DC; Solis, NV1
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C1
Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D1
Camps, SM; Kuijper, EJ; Li, Y; Melchers, WJ; van der Linden, JW; van Dissel, JT; Verweij, PE1
Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Chu, J; Meehan, S; Patel, R; Patel, U1
Granata, JD; Lustenberger, DP; Scharschmidt, TJ1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA1
Buckner, SL; Ceesay, MM; Flanagan, RJ; Morgan, PE; Pagliuca, A1
Isoherranen, N; Kunze, KL; Liu, JO; Lutz, JD; Nelson, WL; Peng, CC; Shi, W1
Lass-Flörl, C1
Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E1
Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V1
Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ1
Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J1
Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE1
Mossad, SB1
Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD1
Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M1
Egerer, G1
Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R1
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C1
Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J1
Harnisch, DO; Proia, LA1
Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E1
Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP1
Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA1
Chen, TC; Chen, YC; Chen, YH; Lu, PL1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G1
Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ1
Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E1
Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Das, S; Gupta, N; Jain, S; Malik, JN1
Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F1
Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S1
Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS1
Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G1
Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L1
Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J1
Aversa, F; Busca, A; Caira, M; Candoni, A; Caramatti, C; Castagnola, C; Cattaneo, C; De Paolis, MR; Delia, M; Di Blasi, R; Di Caprio, L; Fanci, R; Garzia, M; Martino, B; Melillo, L; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Salutari, P; Trecarichi, EM; Tumbarello, M; Verga, L; Vianelli, N1
Curfs-Breuker, I; Fahal, AH; Kloezen, W; Meis, JF; van de Sande, WW1
Falcone, EL; Holland, SM1
Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
Duan, J; Xiong, X; Zhai, S1
Balfour-Lynn, IM; Bentley, S; Gupta, A1
Barclay, ML; Begg, EJ; Moore, GA; Zhang, M1
Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y1
Hunt, S; Papadopoulos, G; Prasad, M1
Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG1
Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y1
Yoshida, M1
Gärtner, P; Knoth, H; Petry, T1
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC1
Shi, Y; Sun, HM; Xu, XY; Zhao, BL1
Furuya, N; Mano, Y; Morishige, H; Oguri, T1
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C1
Athanasakis, K; Kyriopoulos, J; Petrakis, I1
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK1
Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S1
Arnan, M; Clopés, A; de Sevilla, AF; Duarte, RF; Muñoz, C; Patiño, B; Peralta, T; Sánchez-Ortega, I1
Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA1
Li, R; Yu, J; Zhang, S1
Fata, A; Najafzadeh, MJ; Naseri, A1
Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M1
Kontoyiannis, DP; Shirazi, F2
Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M1
Albert, N; Kontoyiannis, DP; Lewis, RE; Pontikos, MA; Shirazi, F; Walsh, TJ1
Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S1
Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS1
Coignard-Biehler, H; Hermine, O; Jullien, V; Lecuit, M; Lortholary, O; Pilmis, B; Touraine, P1
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C1
Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M1
Chen, SC; Meyer, W; Middleton, PG1
Allione, B; Audisio, E; Aydin, S; Barbui, AM; Busca, A; D'Ardia, S; De Rosa, FG; Dellacasa, CM; Falda, M; Frairia, C; Manetta, S; Marmont, F; Pecoraro, C; Vitolo, U1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA1
Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E1
Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J1
Chen, J; Huang, J; Li, L; Yang, Q1
Dorsey, SA; Fothergill, AW; Furmaga, W; Lewis, JS; Patterson, TF; Pennick, GJ; Sutton, DA; Wiederhold, NP1
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó1
de Macedo-Silva, ST; de Souza, W; Rodrigues, JC; Urbina, JA1
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK1
Cogliati, M; De Lorenzis, G; Esposto, MC; Prigitano, A; Tortorano, AM; Venier, V1
Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA1
Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J1
Aguiar, A; Faria, M; Fernandes, C; Lago, M; Natário, A; Pinto, E1
Ahmed, SA; de Hoog, GS; Duncanson, F; Fahal, AH; Kloezen, W; van de Sande, WW; Zijlstra, EE1
Chowdhary, A; Hagen, F; Meis, JF; Sharma, C1
Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H1
Akshita, K; Datry, A; Fekkar, A; Lescar, J; Mazier, D; Meyer, I; Palous, M; Srinivasaraghavan, K; Verma, C1
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y1
Dolton, MJ; McLachlan, AJ1
Chowdhary, A; Dolatabadi, S; Hagen, F; Kathuria, S; Meis, JF; Sharma, B; Singh, PK1
Marcella, SW; Sung, AH; Xie, Y1
Gao, RS; Liu, FF; Lu, L; Pu, L; Xu, XS; Zhang, SZ; Zhang, YW; Zheng, QQ1
Chakrabarti, A; Chowdhary, A; Cordoba, S; Dannaoui, E; Dufresne, P; Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Gonzalez, GM; Guarro, J; Kidd, S; Lass-Flörl, C; Meis, JF; Pelaez, T; Tortorano, AM; Turnidge, J1
Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP1
Fahal, AH; Nenoff, P; Reinel, D; Schöfer, H; van de Sande, WW1
Ikeda, F; Iyoda, T; Mikawa, T; Suzuki, M; Yamaguchi, H1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R1
Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE1
Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P1
Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG1
Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B1
Bulanda, M; Jagielski, T; Skóra, M1
Abdul Halim, NA; Tan, BH; Wong, GC1
Pagano, L; Tumbarello, M1
Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH1
Buettner, B; Knoth, H; Scriba, GK1
de Macedo-Silva, ST; de Souza, W; Rodrigues, JC; Urbina, JA; Visbal, G1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF1
Bishop, R; Boris, L; Freeman, AF; Heller, T; Holland, SM; Jackson, MA; Kleiner, D; McGowan, K; Milligan, KL; Odio, CD; Rudman Spergel, AK; Urban, A; Welch, P1
Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF1
Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ1
Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ1
Bivila, CP; Lee, H; Lee, S; Lim, YW; Park, MS; Xu, S; Yamamoto, N1
Coste, AT; Sanglard, D1
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ1
Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J1
Arendrup, MC; Cuenca-Estrella, M; Jensen, RH1
Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM1
Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S1
Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F1
Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W1
Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS1
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A1
Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ1
Andes, D; Azie, N; Franks, B; Harrington, R; Kelley, C; Khandelwal, N; Kristy, R; Lee, E; Spalding, J; Tan, RD; Wu, EQ; Yang, H1
Brossart, P; Felder, L; Hahn-Ast, C; Hein, R; Hellmich, M; Mayer, K; Mückter, S; Rachow, T; Ruhnke, M; Schwab, K; von Lilienfeld-Toal, M1
Alem, N; Karabıçak, N1
Rosen, T; Stein Gold, LF1
Chanda, S; Coronado, D; Del Rosso, J; Zane, LT1
Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM1
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W1
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H1
Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK1
Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ1
Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF1
Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A1
Augustijns, P; Brouwers, J; Hens, B; Kourentas, A; Reppas, C; Symillides, M; Vertzoni, M1
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B1
Basu, SS; Jarolim, P; Mason, DS; Petrides, A1
Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD1
Brown, MS; Das, A; De Brabander, JK; Goldstein, JL; Li, X; Liang, Q; Lu, F; Trinh, MN1
Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ1
Akram, M; Bächler, M; Beck, KR; Griesser, U; Klusonova, P; Odermatt, A; Schuster, D; Temml, V; Vuorinen, A; Wagner, S; Yamaguchi, H1
Chen, C; Han, HS; Kano, R; Noli, C1
Banjara, N; Florescu, DF; Gomes-Neto, JC; Hallen-Adams, HE; Iwen, PC; Mercer, DF; Suhr, MJ1
Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M1
Chen, F; Feng, CL; He, Q; Shi, Y; Su, X; Zhang, M1
Hope, WW; Stott, KE1
D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE1
Almeida-Paes, R; Brito-Santos, F; Figueiredo-Carvalho, MHG; Gutierrez-Galhardo, MC; Machado, ACS; Oliveira, MME; Pereira, SA; Zancopé-Oliveira, RM1
Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE1
Ashu, EE; Korfanty, GA; Xu, J1
Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ1
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J1
Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S1
Healy, AM; Mugheirbi, NA; O'Connell, P; Serrano, DR; Tajber, L; Taylor, LS1
Gao, L; He, C; Li, M; Sun, Y; Zeng, T1
Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ1
Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J1
Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT1
Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M1
Nix, WA; Rhoden, E; Selvarangan, R; Weldon, WC1
Basak, GW; Brillowska-Dąbrowska, A; Kurzyk, E; Mroczyńska, M; Nawrot, U; Sulik-Tyszka, B; Wróblewska, M; Włodarczyk, K1
Fritz, J; Hagleitner, M; Jukic, E; Lackner, M; Lass-Flörl, C; Rambach, G; Sartori, B; Seger, C; Speth, C1
Augustijns, P; Berben, P; Brouwers, J1
Chang, M; Chang, YC; Khanal Lamichhane, A; Kwon-Chung, KJ; Sionov, E1
Bader, O; Becker, K; Groß, U; Idelevich, EA1
Gong, J; Humphreys, WG; Iacono, L; Iyer, RA; Zheng, M1
Fitzmaurice, S; Fung, M; He, Y; Ma, C1
Canteros, CE; Córdoba, S; Davel, G; Hevia, A; Isla, G; Szusz, W; Vivot, W1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A1
Bartoszewicz, M; Król, J; Nawrot, U1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L1
Andes, D; Desai, A; Kitt, T; Kovanda, L; Walsh, TJ; Zhao, M1
Alcazar-Fuoli, L; Bernal-Martínez, L; Gomez-Lopez, A1
Lipner, SR; Scher, RK1
Bezemer, B; Meutiawati, F; Overheul, GJ; Strating, JRPM; van Cleef, KWR; van Kuppeveld, FJM; van Rij, RP; Žusinaite, E1
McComiskey, KPM; Tajber, L1
Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA1
Keniya, MV; Monk, BC; Sabherwal, M; Sagatova, AA; Tyndall, JDA; Wilson, RK; Woods, MA1
Ge, H; Liang, G; Liu, M; Liu, W; Zheng, H; Zheng, N1
Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L1
Chen, SC; Jeong, W; Keighley, C; Kong, DCM; Lee, WL; Slavin, MA; Wolfe, R1
Abastabar, M; Aslani, N; Badali, H; Bowyer, P; Gholami, S; Haghani, I; Hedayati, MT; Hosseini, T; Lagzian, M; Nazeri, M; Nouripour-Sisakht, S; Shokohi, T; Vakili, M; Valadan, R1
Lewis, JS; Nix, DE; Patterson, TF; Thompson, GR1
Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M1
Brunotte, L; Goretzko, J; Kühnl, A; Ludwig, S; Rescher, U; Schloer, S1
Chau, LQ; Dash, RC; Hadden, MK; Pace, JR; Teske, KA; Wechsler-Reya, RJ; Zaino, AM1
Alastruey-Izquierdo, A; de Hoog, S; Kurzai, O; Voigt, K; Wagner, L; Walther, G1
Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X1
Aramaki, C; Kamata, H; Kano, R; Mori, Y; Murayama, N; Yamagishi, K; Yokoi, S1
Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA1
Dannaoui, E; Schwarz, P; Vidal, P1
Braga, SS1
Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K1
Li, R; Sun, L; Wan, Z; Yu, J1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K1
Kyle Hadden, M; Teske, KA; Wen, J1
Ito, T; Kamata, H; Kano, R; Miura, A; Suzuki, K1
Appeltans, B; Pas, T; Van den Mooter, G; Verbert, S1
Atanasova, L; Bogáts, G; Büchner, R; Cai, F; Chenthamara, K; Dóczi, I; Druzhinina, IS; Hatvani, L; Homa, M; Kocsubé, S; Kredics, L; Manikandan, P; Mlinaric-Missoni, E; Narendran, V; Revathi, R; Vágvölgyi, C1
Briesach, L; Campagnoli, R; Konopka-Anstadt, J; Ng, TFF; Nix, WA; Oberste, MS; Rhoden, E; Selvarangan, R; Weldon, WC1
Bigot, J; Botterel, F; Bougnoux, ME; Dannaoui, E; Dellière, S; Fekkar, A; Guitard, J; Hennequin, C; Senghor, Y; Verdurme, L1
Harada, K; Hase, M; Hiruma, J; Hiruma, M; Kamata, H; Kano, R; Noguchi, H; Yokota, M1
Hirano, A; Murata, M; Muto, M; Shimomura, Y; Yamada, T1
Athans, V; Brizendine, KD; Cober, E; Copley, MS; Siebenaller, C; Waldron, M; Welch, SC1
Beck, KR; Odermatt, A; Telisman, L; Thompson, GR; van Koppen, CJ1
Kauffman, CA; Schwartz, IS1
Li, H; Tu, B; Yin, G1
Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M1
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS1
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL1
Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y1
Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J1
Tratrat, C1
Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M1
Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y1
Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A1
Inderbinen, SG; Kley, M; Odermatt, A; Smieško, M; Zogg, M1
Agarwal, R; Chakrabarti, A; Choudhary, H; Ghosh, A; Kaur, H; Rudramurthy, SM; Singh, R; Singh, S1
Geizhals, S; Lipner, SR1
Catto, M; Ivanov, M; Kritsi, E; Lecinska, P; Sokovic, M; Zoidis, G; Zoumpoulakis, P1
Castanheira, M; Collingsworth, TD; Davis, AP; Deshpande, LM; Pfaller, MA1
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM1
Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW1
Abutarif, M; Hong, Y; Ishizuka, H; Ishizuka, T; LaCreta, F; Lee, M; Tachibana, M; Watanabe, A1
Irlbeck, M; Jung, J; Kallee, S; Kneidinger, N; Liebchen, U; Michel, S; Paal, M; Scharf, C; Schneider, C; Schroeder, I; Vogeser, M; Zander, J; Zoller, M1
Eadie, K; Fahal, AH; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A1
Bafghi, MH; Darroudi, M; Nazari, R; Zargar, M; Zarrinfar, H1
Amidon, GE; Kataoka, M; Minami, K; Takagi, T; Yamashita, S1
Couraud, S; Dannaoui, E; Déméautis, T; Devouassoux, G; Dupont, D; Durieu, I; Garnier, H; Kramer, R; Lina, B; Menotti, J; Persat, F; Rabodonirina, M; Reix, P; Sénéchal, A; Simon, L; Wallon, M1
Guillot, J; Rezaei-Matehkolaei, A; Shamsizadeh, F; Shariat Nabavi, M; Taghipour, S; Zarei Mahmoudabadi, A1
Chen, L; Chen, W; Li, L1
Gao, L; Sun, Y; Tan, L; Yang, J; Yao, Z; Zeng, T1
Ito, H; Ogawa, R1
Abastabar, M; Badali, H; Bonifaz, A; Fahal, A; Lim, W; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A1
Bakhiet, S; Fahal, AH; Mhmoud, NA; Nyaoke, BA; Nyuykonge, B; Siddig, EE; van de Sande, WWJ; Verbon, A; Zijlstra, EE1
Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z1
Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T1
Chen, P; Chen, Y; Feng, Z; Gao, F; Jin, Y; Lin, W; Lu, C; Shang, Z; Wang, F; Yang, J1
Chen, H; Chen, X; Du, M; Jiang, Y; Lei, W; Meng, H; Xue, X; Zhang, S1
Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G1
Goldstein, EJ; Sircar, AD; Tran, MN; Vaidya, SA; Wheat, LJ1
Bamba, S; Denis, O; Lagrou, K; Montesinos, I; Nakanabo Diallo, S; Resendiz-Sharpe, A; Rodriguez-Villalobos, H; Rouamba, T; Yerbanga, IW1
Cha, JH; Cho, Y; Choi, H; Kim, J; Kim, KJ; Lee, CK; Nam, M; Nam, MH; Yim, J; Yun, SG1
Bazydlo, L; Girton, M; Tomsig, J1

Reviews

73 review(s) available for triazoles and itraconazole

ArticleYear
Fungal infections and their management.
    British journal of clinical practice. Supplement, 1990, Volume: 71

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles

1990
Testing of organisms for susceptibility to triazoles: is it justified?
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1989
New antifungal agents.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles

1989
Azole antifungal agents: emphasis on new triazoles.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1

    Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles

1988
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1987
Azole antifungal drugs: old and new.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1988
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1988
New oral treatments for dermatophytosis.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles

1988
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles

1996
Use of azoles for systemic antifungal therapy.
    Advances in pharmacology (San Diego, Calif.), 1997, Volume: 39

    Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1997
[Superficial mycoses in immunosuppressed patients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles

1995
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Feb-01, Volume: 55, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Triazoles

1998
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
    Mycopathologia, 2001, Volume: 150, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole

2001
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000
[Present status and future prospects of azole antifungal agents in Japan].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6

    Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
[Clinical development of antimycotics. Medical challenges].
    Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole

2003
History of the development of azole derivatives.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10 Suppl 1

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole

2004
CNS-aspergillosis: are there new treatment options?
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-21, Volume: 148, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2004
[Invasive aspergillosis: clinical manifestations and treatment].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole

2003
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
    Respiratory medicine, 2004, Volume: 98, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Azoles; Evidence-Based Medicine; Forecasting; Humans; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole

2004
Pharmacological management of paracoccidioidomycosis.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:3

    Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole

2005
[Update on therapy of invasive mycoses in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2005
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
[Drug-drug interaction of antifungal drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
[The future of antifungal agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2007
Fusarium infections of the skin.
    Current opinion in infectious diseases, 2007, Volume: 20, Issue:2

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2007
[New development in the treatment of deep-seated mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles

2008
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal agents--clinical pharmacokinetics and drug interactions.
    Mycoses, 2008, Volume: 51 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2008
Treatment of invasive candidal infections: systematic review and meta-analysis.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:4

    Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole

2010
Onychomycosis.
    Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole

2010
Traditional and emerging antifungal therapies.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2010
Conazoles.
    Molecules (Basel, Switzerland), 2010, Jun-09, Volume: 15, Issue:6

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole

2010
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
    Lung, 2011, Volume: 189, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole

2011
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
    European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2011
Anidulafungin: when and how? The clinician's view.
    Mycoses, 2012, Volume: 55, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation Rate; Phenotype; Polymorphism, Single Nucleotide; Sputum; Time Factors; Triazoles

2012
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Triazole antifungal agents in invasive fungal infections: a comparative review.
    Drugs, 2011, Dec-24, Volume: 71, Issue:18

    Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
    Nederlands tijdschrift voor geneeskunde, 2012, Volume: 156, Issue:25

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole

2012
Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
    Current opinion in infectious diseases, 2012, Volume: 25, Issue:6

    Topics: Antifungal Agents; Granulomatous Disease, Chronic; Humans; Itraconazole; Mycoses; Surgical Procedures, Operative; Triazoles

2012
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult

2013
Fungal infections and treatment in cystic fibrosis.
    Current opinion in pulmonary medicine, 2013, Volume: 19, Issue:6

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole

2013
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
    Mycoses, 2014, Volume: 57, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole

2014
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole

2014
What is new in fungal pharmacotherapeutics?
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:4

    Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles

2014
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Future microbiology, 2014, Volume: 9, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole

2014
Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:10

    Topics: Actinomycetales; Actinomycetales Infections; Amputation, Surgical; Animals; Anti-Bacterial Agents; Antifungal Agents; Cytokines; Debridement; Diagnosis, Differential; Humans; Inflammation; Itraconazole; Madurella; Mycetoma; Naphthalenes; Terbinafine; Triazoles

2015
Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome.
    The Journal of allergy and clinical immunology, 2015, Volume: 136, Issue:5

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Coccidioides; Coccidioidomycosis; Colon; Cryptococcosis; Cryptococcus; Duodenal Ulcer; Endemic Diseases; Female; Histoplasma; Histoplasmosis; Humans; Itraconazole; Job Syndrome; Male; Middle Aged; Mutation; STAT3 Transcription Factor; Treatment Outcome; Triazoles; United States

2015
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole

2016
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Dermatology online journal, 2016, Mar-16, Volume: 22, Issue:3

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2016
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole

2017
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole

2018
Disseminated cutaneous sporotrichosis presenting as a necrotic facial mass: Case and review.
    Dermatology online journal, 2017, Jul-15, Volume: 23, Issue:7

    Topics: Aged; Antifungal Agents; Diagnosis, Differential; Face; Female; Humans; Immunocompromised Host; Itraconazole; Necrosis; Sporothrix; Sporotrichosis; Triazoles

2017
Onychomycosis: Treatment and prevention of recurrence.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles

2019
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
    International journal of antimicrobial agents, 2019, Volume: 53, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Management; Drug Therapy, Combination; Female; Humans; Itraconazole; Male; Middle Aged; Mucormycosis; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome; Triazoles; Young Adult

2019
Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
    Medical mycology, 2019, Feb-01, Volume: 57, Issue:Supplement

    Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Triazoles

2019
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole

2019
Blastomycosis.
    Seminars in respiratory and critical care medicine, 2020, Volume: 41, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole

2020
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Expert review of respiratory medicine, 2020, Volume: 14, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole

2020
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole

2020
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.
    Current topics in medicinal chemistry, 2020, Volume: 20, Issue:24

    Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Invasive; Drug Design; Fluconazole; Humans; Itraconazole; Structure-Activity Relationship; Treatment Outcome; Triazoles

2020
A Timeline of Onychomycosis Therapy and Future Directions.
    Skinmed, 2020, Volume: 18, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Humans; Itraconazole; Nail Diseases; Onychomycosis; Terbinafine; Triazoles

2020
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:9

    Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole

2021
Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review.
    Journal de mycologie medicale, 2023, Volume: 33, Issue:4

    Topics: Agar; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Triazoles; Voriconazole

2023

Trials

15 trial(s) available for triazoles and itraconazole

ArticleYear
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-15, Volume: 41, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2005
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    The American journal of medicine, 2006, Volume: 119, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2006
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-15, Volume: 44, Issue:4

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles

2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles

2007
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-01, Volume: 45, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Pilot Projects; Pyrimidines; Triazoles; Voriconazole

2007
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2008
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: Amphotericin B; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult

2009
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Triazoles; Young Adult

2009
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles

2010
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
    British journal of haematology, 2011, Volume: 155, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2011
Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Limit of Detection; Male; Middle Aged; Neutropenia; Reproducibility of Results; Spectrometry, Fluorescence; Triazoles; Young Adult

2011
Voriconazole for fungal corneal ulcers.
    Ophthalmology, 2012, Volume: 119, Issue:5

    Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2012
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:11

    Topics: Aged; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Triazoles

2012

Other Studies

550 other study(ies) available for triazoles and itraconazole

ArticleYear
Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
    Chemotherapy, 1992, Volume: 38, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Disease Models, Animal; Itraconazole; Ketoconazole; Male; Rats; Rats, Inbred Strains; Triazoles

1992
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles

1992
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:3

    Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles

1990
Treatment of murine coccidioidal meningitis with SCH39304.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4

    Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Mice; Mice, Inbred BALB C; Triazoles

1990
Treatment of chronic murine chromoblastomycosis with the triazole SCH39304.
    The American journal of tropical medicine and hygiene, 1990, Volume: 42, Issue:6

    Topics: Animals; Antifungal Agents; Chromoblastomycosis; Chronic Disease; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Mitosporic Fungi; Skin; Triazoles

1990
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3

    Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles

1990
[Recent antifungal agents].
    Pathologie-biologie, 1989, Volume: 37, Issue:2

    Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles

1989
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2

    Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles

1989
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
    Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles

1989
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
    Chemotherapy, 1989, Volume: 35, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles

1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles

1987
[New antiparasitic drugs].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:4

    Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles

1988
Improved method for azole antifungal susceptibility testing.
    Journal of clinical microbiology, 1988, Volume: 26, Issue:9

    Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles

1988
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
    Molecular and biochemical parasitology, 1988, Volume: 31, Issue:2

    Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Leishmania; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Sterols; Triazoles

1988
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure-Activity Relationship; Tinea Versicolor; Triazoles

1988
The new generation of antifungal drugs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:6

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles

1988
Efficacies of four antifungal agents in experimental murine sporotrichosis.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole; Mice; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles

1988
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
    Mykosen, 1985, Volume: 28, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles

1985
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:1

    Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles

1985
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Journal of general microbiology, 1985, Volume: 131, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles

1985
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4

    Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles

1986
New and prospective developments in antifungal drugs.
    Acta dermato-venereologica. Supplementum, 1986, Volume: 121

    Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles

1986
Azole resistance in Candida albicans.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2

    Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles

1986
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Mycopathologia, 1986, Volume: 94, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles

1986
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Mice; Potassium Iodide; Sporothrix; Sporotrichosis; Triazoles

1986
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles

1987
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:1

    Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles

1987
In vitro studies with R 51,211 (itraconazole).
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:1

    Topics: Antifungal Agents; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Morpholines; Triazoles

1984
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles

1984
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis, Vulvovaginal; Cryptococcus neoformans; Dermatomycoses; Female; Guinea Pigs; Itraconazole; Ketoconazole; Microsporum; Phialophora; Rats; Rats, Inbred Strains; Sporothrix; Triazoles; Trichophyton

1984
Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Female; Immunosuppression Therapy; Itraconazole; Leukocyte Count; Lung Diseases, Fungal; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Neutrophils; Triazoles

1995
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Evaluation; Female; Itraconazole; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate; Triazoles

1995
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5

    Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles

1995
Functional expression of Saccharomyces cerevisiae CYP51A1 encoding lanosterol-14-demethylase in tobacco results in bypass of endogenous sterol biosynthetic pathway and resistance to an obtusifoliol-14-demethylase herbicide inhibitor.
    The Plant journal : for cell and molecular biology, 1995, Volume: 7, Issue:5

    Topics: Cholestadienols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance; Fungal Proteins; Herbicides; Itraconazole; Ketoconazole; Nicotiana; Oxidoreductases; Plants, Genetically Modified; Plants, Toxic; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Silanes; Sterol 14-Demethylase; Sterols; Triazoles

1995
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Triazoles

1995
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
    Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:2

    Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles

1994
Pneumocystis carinii is resistant to imidazole antifungal agents.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:8

    Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles

1994
In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Stereoisomerism; Triazoles

1993
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Electrophoresis; Enzymes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

1995
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Blood; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Rabbits; Triazoles

1996
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1997
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles

1997
In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1

    Topics: Antifungal Agents; Candida; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Reference Standards; Solvents; Temperature; Triazoles

1997
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles

1997
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Itraconazole; Lung; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole

1997
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1997
In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5

    Topics: Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Triazoles

1997
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Diagnostic microbiology and infectious disease, 1997, Volume: 27, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles

1997
Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Itraconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Neutropenia; Survival Rate; Time Factors; Triazoles

1997
Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Evaluation, Preclinical; Female; Itraconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Triazoles

1997
In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:6

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Carbon Monoxide; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Ergosterol; Fluconazole; Itraconazole; Time Factors; Triazoles

1997
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:10

    Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles

1997
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activity of voriconazole against Candida species.
    Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:1

    Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole

1998
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:10

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole

1998
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
    Mycopathologia, 1998, Volume: 141, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

1998
In vitro activity of voriconazole against selected fungi.
    Medical mycology, 1998, Volume: 36, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Environmental Microbiology; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

1998
Organism-dependent fungicidal activities of azoles.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Dose-Response Relationship, Drug; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole

1999
Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Histoplasma; Histoplasmosis; Immunocompetence; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles

1999
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

1999
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

1999
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1999
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole

1999
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:6

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

1999
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:9

    Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Thiazoles; Triazoles

1999
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:2

    Topics: Antifungal Agents; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Quinazolines; Triazoles

1999
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
    Diagnostic microbiology and infectious disease, 1999, Volume: 35, Issue:2

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles

1999
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
    Mycoses, 1999, Volume: 42, Issue:9-10

    Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes

1999
In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles

2000
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Colony Count, Microbial; Disease Models, Animal; Female; Immunosuppression Therapy; Itraconazole; Microbial Sensitivity Tests; Rabbits; Triazoles

2000
SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Central Nervous System Fungal Infections; Disease Models, Animal; Female; Itraconazole; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Triazoles

2000
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Blastomyces; Coccidioides; Histoplasma; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2000
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole

2000
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles

2000
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Histoplasma; Histoplasmosis; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Lung; Mice; Mice, Inbred Strains; Spleen; Survival Analysis; Time Factors; Triazoles

2000
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

    Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles

2000
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole

2000
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole

2000
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole

2000
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Antifungal Agents; Aspergillus; Coloring Agents; Dye Dilution Technique; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Galactose; Itraconazole; Lung Diseases, Fungal; Mannans; Neutropenia; Rabbits; Treatment Outcome; Triazoles

2001
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2001
Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, Mar-05, Volume: 752, Issue:1

    Topics: Animals; Antifungal Agents; Atmospheric Pressure; Chromatography, High Pressure Liquid; Itraconazole; Mass Spectrometry; Piperazines; Quality Control; Rats; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2001
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
    Medical mycology, 2001, Volume: 39, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2001
[Invasive aspergillosis on a surgical intensive care unit].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2000
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole

2000
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
    Electrophoresis, 2001, Volume: 22, Issue:12

    Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole

2001
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
    Medical mycology, 2001, Volume: 39, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2001
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

2001
In vitro activity of posaconazole against clinical isolates of dermatophytes.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:11

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

2001
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2001
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758.
    Chemical & pharmaceutical bulletin, 2001, Volume: 49, Issue:12

    Topics: Antifungal Agents; Fluconazole; Fungi; Indicators and Reagents; Itraconazole; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Triazoles

2001
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Diagnostic microbiology and infectious disease, 2001, Volume: 41, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2001
Azole cross-resistance in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Resistance, Multiple; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
    Archives of oral biology, 2002, Volume: 47, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genetic Heterogeneity; HIV Infections; Humans; Itraconazole; Karyotyping; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Triazoles

2002
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:3

    Topics: Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Histoplasmosis; Itraconazole; Liver; Mice; Spleen; Survival; Survival Analysis; Thiazoles; Triazoles

2002
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
    Deutsche medizinische Wochenschrift (1946), 2002, Mar-08, Volume: 127, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2002
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:5

    Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole

2002
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7

    Topics: Adult; Antifungal Agents; Humans; Hyphae; Itraconazole; Neutrophils; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2002
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole

2002
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2002
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
    Bioorganic & medicinal chemistry letters, 2002, Oct-07, Volume: 12, Issue:19

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prodrugs; Rats; Solubility; Thiazoles; Triazoles

2002
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2002
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
    American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:2

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole

2003
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2

    Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole

2003
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:3

    Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole

2003
Drug induced proteome changes in Candida albicans: comparison of the effect of beta(1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazole.
    Proteomics, 2003, Volume: 3, Issue:3

    Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Electrophoresis, Gel, Two-Dimensional; Fluconazole; Fungal Proteins; Glucose; Glucosyltransferases; Image Processing, Computer-Assisted; Itraconazole; Kinetics; Mass Spectrometry; Membrane Proteins; Microscopy, Electron, Scanning; Microscopy, Phase-Contrast; Peptides, Cyclic; Proteome; Schizosaccharomyces pombe Proteins; Triazoles

2003
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2003
Synthesis and antimycotic activity of N-azolyl-2,4-dihydroxythiobenzamides.
    Bioorganic & medicinal chemistry, 2003, May-15, Volume: 11, Issue:10

    Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Thioamides; Triazoles

2003
An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
    Journal of cutaneous pathology, 2003, Volume: 30, Issue:5

    Topics: Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Male; Pyrimidines; Skin; Triazoles; Voriconazole

2003
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole

2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole

2003
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
    Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:9

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole

2003
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole

2003
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Flow Cytometry; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Activity of posaconazole in treatment of experimental disseminated zygomycosis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Absidia; Amphotericin B; Animals; Antifungal Agents; Brain; Female; Itraconazole; Kidney; Mice; Microbial Sensitivity Tests; Rhizopus; Triazoles; Zygomycosis

2003
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole

2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles

2004
In vitro and in vivo activities of the novel azole antifungal agent r126638.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2

    Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Itraconazole; Ketoconazole; Mice; Microbial Sensitivity Tests; Microsporidia; Skin; Tinea; Triazoles; Trichophyton

2004
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole

2004
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole

2004
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Mycoses, 2004, Volume: 47, Issue:5-6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2004
The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Adrenal Cortex; Androgens; Animals; Antifungal Agents; Candida albicans; Cattle; Cells, Cultured; Cholesterol; Cytochrome P-450 Enzyme System; Epidermis; Ergosterol; Estrogens; Humans; Imidazoles; In Vitro Techniques; Itraconazole; Kidney; Male; Microsomes; Microsomes, Liver; Microsporum; Mitochondria; Pharmaceutical Preparations; Placenta; Rats; Rats, Wistar; Steroid 11-beta-Hydroxylase; Testis; Tretinoin; Triazoles; Trichophyton

2004
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2004
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2004
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Transplantation; Treatment Outcome; Triazoles; Voriconazole

2005
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Cell Membrane; Cholesterol; Culture Media, Conditioned; Ergosterol; Humans; Itraconazole; Magnetic Resonance Spectroscopy; Oxygen Consumption; Pyrimidines; Spores, Fungal; Sterols; Triazoles; Voriconazole

2005
Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Base Sequence; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Triazoles

2005
[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colorimetry; Fluorescence; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole

2005
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Dermatologic Agents; Guinea Pigs; Imidazoles; Itraconazole; Mice; Mitosporic Fungi; Mycoses; Naphthalenes; Stereoisomerism; Structure-Activity Relationship; Terbinafine; Triazoles

2005
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole

2005
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
    Mycoses, 2005, Volume: 48 Suppl 1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole

2005
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Medical mycology, 2005, Volume: 43, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts

2005
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-15, Volume: 40, Issue:12

    Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
Management of cryptococcosis in non-HIV-related patients.
    Medical mycology, 2005, Volume: 43, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles

2005
Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Ultraviolet Rays; Voriconazole

2005
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:8

    Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2005
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
    Annals of diagnostic pathology, 2005, Volume: 9, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2005, Volume: 46, Issue:3

    Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole

2005
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts

2005
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2005
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole

2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:9

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole

2005
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:9

    Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
    Mycopathologia, 2005, Volume: 160, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole

2005
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:9

    Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
In vitro susceptibility of oral Candida to seven antifungal agents.
    Oral microbiology and immunology, 2005, Volume: 20, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole

2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole

2005
[Physiological comportment and in vivo sensitivity of Sporothrix schenckii isolates maintained for 18 years by two preservation methods].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Agar; Antifungal Agents; Drug Resistance, Fungal; Glucose; Itraconazole; Microbial Sensitivity Tests; Mycology; Naphthalenes; Potassium Iodide; Preservation, Biological; Sporothrix; Starch; Terbinafine; Time Factors; Triazoles; Water

2005
Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Medical mycology, 2005, Volume: 43, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
    Medical mycology, 2005, Volume: 43, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Fungal; Growth Substances; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Serum Albumin; Triazoles; Voriconazole

2005
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts

2006
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2006
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:5

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole.
    Mycopathologia, 2006, Volume: 162, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Benzenesulfonates; Fluorescent Dyes; Itraconazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Propidium; Pyrimidines; Triazoles; Voriconazole

2006
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    The Veterinary record, 2006, Aug-26, Volume: 159, Issue:9

    Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2006
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole

2006
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Multi-azole resistance in Aspergillus fumigatus.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2006
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology

2007
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
    Journal of clinical microbiology, 2007, Volume: 45, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole

2007
Antifungal activities of azole agents against the Malassezia species.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:3

    Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole

2007
Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:4

    Topics: Aniline Compounds; Aryl Hydrocarbon Hydroxylases; Benzodioxoles; Binding Sites; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Heme; Humans; Imidazoles; Itraconazole; Kinetics; Ligands; Light; Models, Chemical; Molecular Structure; NADP; Nonlinear Dynamics; Protein Binding; Pyrimidines; Recombinant Proteins; Reference Standards; Regression Analysis; Spectrum Analysis; Sulfaphenazole; Triazoles

2007
Prophylaxis and aspergillosis--has the principle been proven?
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles

2007
[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
    Archivos de bronconeumologia, 2007, Volume: 43, Issue:1

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    Archives of dermatological research, 2007, Volume: 299, Issue:2

    Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole

2007
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Mycopathologia, 2007, Volume: 163, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2007
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
    Current eye research, 2007, Volume: 32, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole

2007
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:4

    Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole

2006
Posaconazole.
    Nature reviews. Drug discovery, 2007, Volume: 6, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States

2007
Nasofacial phycomycosis: persistence pays.
    The Journal of craniofacial surgery, 2007, Volume: 18, Issue:2

    Topics: Adult; Antifungal Agents; Conidiobolus; Drug Resistance, Fungal; Facial Dermatoses; Female; Humans; Itraconazole; Pyrimidines; Timor-Leste; Triazoles; Voriconazole; Zygomycosis

2007
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Chemotherapy, 2007, Volume: 53, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole

2007
[Correlations among itraconazole, voriconazole and posaconazole MICs in Aspergillus fumigatus].
    Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:12

    Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole

2007
[Perspectives on allergic bronchopulmonary aspergillosis].
    Revue des maladies respiratoires, 2007, Volume: 24, Issue:5

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles

2007
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole

2008
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Mycoses, 2007, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
    Yonsei medical journal, 2007, Oct-31, Volume: 48, Issue:5

    Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2007
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole

2008
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Canadian journal of microbiology, 2007, Volume: 53, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Chemotherapy, 2008, Volume: 54, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole

2008
Solitary cutaneous nodule in an immunocompromised patient.
    Archives of dermatology, 2007, Volume: 143, Issue:12

    Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole

2007
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
    Medical mycology, 2008, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    International journal of laboratory hematology, 2008, Volume: 30, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2008
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2008
Imidazole antifungals, but not triazole antifungals, increase membrane Zn2+ permeability in rat thymocytes Possible contribution to their cytotoxicity.
    Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3

    Topics: Animals; Antifungal Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chlorides; Clotrimazole; Dose-Response Relationship, Drug; Fluconazole; Imidazoles; Itraconazole; Male; Rats; Rats, Wistar; Structure-Activity Relationship; T-Lymphocytes; Thymus Gland; Triazoles; Zinc Compounds

2008
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2008
Successful treatment of histoplasmosis brain abscess with voriconazole.
    Archives of neurology, 2008, Volume: 65, Issue:5

    Topics: Adult; Antifungal Agents; Arm; Bone Marrow Diseases; Brain Abscess; Cerebellar Ataxia; Cerebellum; Frontal Lobe; Histoplasmosis; Humans; Itraconazole; Liver Abscess; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Treatment of aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Aug-01, Volume: 47, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles

2008
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult

2008
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Medical mycology, 2009, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult

2009
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
    Medical mycology, 2009, Volume: 47, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
    European journal of haematology, 2008, Volume: 81, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2008
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2008
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
    Chemical biology & drug design, 2008, Volume: 72, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole

2008
Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
    Bioorganic & medicinal chemistry letters, 2008, Dec-15, Volume: 18, Issue:24

    Topics: Antifungal Agents; Carbon; Chemistry, Pharmaceutical; Dioxanes; Drug Design; Epoxy Compounds; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Models, Chemical; Stereoisomerism; Triazoles

2008
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
    American journal of veterinary research, 2008, Volume: 69, Issue:11

    Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole

2008
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    PLoS medicine, 2008, Nov-11, Volume: 5, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2008
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2009
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Dec-01, Volume: 65, Issue:23

    Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles

2008
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2008, Volume: 23, Issue:10

    Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2008
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2008
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2009
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
    Le infezioni in medicina, 2008, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole

2008
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Medical mycology, 2008, Volume: 46, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2008
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    The Journal of infectious diseases, 2009, May-01, Volume: 199, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drosophila; Fungi; Humans; Itraconazole; Mice; Mucor; Pyrimidines; Rhizopus; Triazoles; Virulence; Voriconazole; Zygomycosis

2009
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
    Le infezioni in medicina, 2009, Volume: 17, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2009
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:2

    Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Azoles; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Mucorales; Rhizopus; Sirolimus; Tacrolimus; Thiazoles; Triazoles

2009
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
    The Journal of laryngology and otology, 2009, Volume: 123, Issue:9

    Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2009
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole

2009
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
    Mycopathologia, 2009, Volume: 168, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole

2009
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
    Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5

    Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole

2009
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2

    Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
    Emerging infectious diseases, 2009, Volume: 15, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2009
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:9

    Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2009
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2009
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:6

    Topics: Adult; Amino Acid Substitution; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Azoles; Bronchitis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Middle Aged; Mutation, Missense; Plasma; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
    Bone marrow transplantation, 2010, Volume: 45, Issue:4

    Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
Discovery of highly potent novel antifungal azoles by structure-based rational design.
    Bioorganic & medicinal chemistry letters, 2009, Oct-15, Volume: 19, Issue:20

    Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole

2009
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts

2010
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:6

    Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2010
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
    Medical mycology, 2010, Volume: 48, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole

2010
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole

2010
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2010
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole

2010
Use of a high-resolution melt assay to characterize codon 54 of the cyp51A gene of Aspergillus fumigatus on a Rotor-Gene 6000 instrument.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Codon; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Genetic Testing; Glycine; Itraconazole; Microbial Sensitivity Tests; Nucleic Acid Denaturation; Sequence Analysis, DNA; Triazoles

2010
[Exophytic and ulcerative lesions on the lower limb in a Moroccan patient].
    Medicina clinica, 2011, Oct-15, Volume: 137, Issue:10

    Topics: Antifungal Agents; Ascomycota; Combined Modality Therapy; Debridement; Dermatomycoses; Humans; Itraconazole; Leg Ulcer; Male; Middle Aged; Mitosporic Fungi; Morocco; Triazoles

2011
Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7

    Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Exophiala; Injections, Intraperitoneal; Itraconazole; Male; Mice; Mycoses; Treatment Outcome; Triazoles

2010
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pyrimidines; Reference Standards; Triazoles; Voriconazole

2010
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:6

    Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole

2010
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole

2010
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2010
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole

2010
Two new species of Mucor from clinical samples.
    Medical mycology, 2011, Volume: 49, Issue:1

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Phylogeny; Sequence Analysis, DNA; Temperature; Triazoles; United States

2011
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2010
Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
    Southern medical journal, 2010, Volume: 103, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Itraconazole; Lung; Mycetoma; Pneumothorax; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Itraconazole; Male; Middle Aged; Mycoses; Triazoles

2011
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole

2010
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole

2010
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
    Dermatology online journal, 2010, Aug-15, Volume: 16, Issue:8

    Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2010
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2010
In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Dermatitis; Female; Guinea Pigs; Humans; Imidazoles; Inhibitory Concentration 50; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Triazoles; Vaginitis

2010
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Austria; Azoles; Denmark; Drug Resistance, Fungal; Environmental Microbiology; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2010
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
    Chinese medical journal, 2010, Volume: 123, Issue:14

    Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole

2010
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2010
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:12

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Environmental Microbiology; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Naphthalenes; Peptide Elongation Factor 1; Phylogeny; Sequence Analysis, DNA; Spores, Fungal; Temperature; Terbinafine; Triazoles

2010
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:11

    Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles

2011
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Chinese medical journal, 2010, Volume: 123, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Geotrichosis; Humans; Itraconazole; Japan; Male; Middle Aged; Pyrimidines; Remission Induction; Triazoles; Voriconazole

2010
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole

2011
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
    Journal of Korean medical science, 2010, Volume: 25, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Triazoles

2011
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole

2011
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
    Medical mycology, 2011, Volume: 49, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole

2011
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
    The Veterinary record, 2011, Feb-26, Volume: 168, Issue:8

    Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2011
Oral Candida isolates among HIV-infected subjects in Nigeria.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:3

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole

2011
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole

2011
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2011
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Medical mycology, 2012, Volume: 50, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Veterinary microbiology, 2011, Aug-26, Volume: 152, Issue:1-2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
    Ophthalmology, 2011, Volume: 118, Issue:9

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult

2011
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole

2011
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2011
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Mycopathologia, 2011, Volume: 172, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole

2011
Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
    PloS one, 2011, Volume: 6, Issue:7

    Topics: Animals; Antimalarials; Atorvastatin; Catalytic Domain; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; L-Lactate Dehydrogenase; Malaria; Mice; Plasmodium falciparum; Pyrroles; Triazoles

2011
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts

2011
Curvularia lunata endophthalmitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:5

    Topics: Antifungal Agents; Ascomycota; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Humans; Itraconazole; Male; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2011
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Fungi; Fusarium; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
    Mycoses, 2012, Volume: 55, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole

2012
Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Membrane; Chemoprevention; Epithelial Cells; Humans; Itraconazole; Lung; Macrophages; Mycoses; Triazoles

2011
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Veterinary microbiology, 2012, Mar-23, Volume: 155, Issue:2-4

    Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole

2012
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2012
Subcutaneous dematiaceous fungal infection.
    Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole

2011
Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
    Orthopedics, 2011, Nov-09, Volume: 34, Issue:11

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Drug Substitution; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Periostitis; Postoperative Complications; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Haematologica, 2012, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2012
Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:3

    Topics: Antifungal Agents; Azoles; Binding Sites; Catalytic Domain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dioxolanes; Female; Heme; Humans; Hydroxylation; Iron; Itraconazole; Male; Metabolic Networks and Pathways; Midazolam; Stereoisomerism; Triazoles

2012
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole

2012
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
    The American journal of the medical sciences, 2012, Volume: 343, Issue:2

    Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole

2012
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2012
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole

2012
Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation.
    Bone marrow transplantation, 2012, Volume: 47, Issue:10

    Topics: Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Itraconazole; Male; Mycoses; Triazoles

2012
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:1

    Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole

2012
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
    BMC infectious diseases, 2012, Apr-03, Volume: 12

    Topics: Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Spain; Triazoles

2012
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Le infezioni in medicina, 2012, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole

2012
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
    Mycoses, 2012, Volume: 55 Suppl 2

    Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole

2012
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Mycoses, 2013, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

2013
EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

2012
Successful use of posaconazole for treatment of blastomycosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Adult; Antifungal Agents; Blastomycosis; Female; Humans; Itraconazole; Male; Middle Aged; Triazoles

2012
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult

2012
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
    Chinese medical journal, 2012, Volume: 125, Issue:7

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles

2012
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    The Kaohsiung journal of medical sciences, 2012, Volume: 28, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
    Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole

2013
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012, Volume: 106, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Azole preexposure affects the Aspergillus fumigatus population in patients.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole

2012
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pulmonary Aspergillosis; Time Factors; Triazoles

2012
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole

2012
Sarcoid-like reaction in Cryptococcus neoformans infection.
    BMJ case reports, 2012, Jul-27, Volume: 2012

    Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole

2012
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:10

    Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult

2012
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
    Blood, 2012, Sep-20, Volume: 120, Issue:12

    Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2012
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
    FEMS yeast research, 2012, Volume: 12, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole

2012
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole

2012
In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Mycetoma; Nitriles; Pyridines; Triazoles

2012
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
    Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:1

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2013
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in h
    Clinical chemistry and laboratory medicine, 2013, Volume: 51, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Chromatography, Liquid; Drug Monitoring; Humans; Itraconazole; Liquid-Liquid Extraction; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2013
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole

2013
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2013
Adapting a global cost-effectiveness model to local country requirements: posaconazole case study.
    Journal of medical economics, 2013, Volume: 16, Issue:3

    Topics: Antifungal Agents; Cost-Benefit Analysis; Developed Countries; Drug Therapy, Combination; Fluconazole; Fungi; Humans; Itraconazole; Models, Economic; Mycoses; Triazoles

2013
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole

2013
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon

2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
    Die Pharmazie, 2012, Volume: 67, Issue:12

    Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole

2012
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
    The Indian journal of medical research, 2012, Volume: 136, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole

2012
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
    Journal of medical economics, 2013, Volume: 16, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles

2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult

2013
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
    Journal of medical economics, 2013, Volume: 16, Issue:6

    Topics: Antifungal Agents; Cancer Care Facilities; Confidence Intervals; Cost-Benefit Analysis; Fluconazole; Health Resources; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Observational Studies as Topic; Spain; Triazoles

2013
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole

2013
Drug combinations against Mucor irregularis in vitro.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles

2013
First case of Tritirachium oryzae as agent of onychomycosis and its susceptibility to antifungal drugs.
    Mycopathologia, 2013, Volume: 176, Issue:1-2

    Topics: Adult; Antifungal Agents; Basidiomycota; DNA, Fungal; DNA, Ribosomal Spacer; Female; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Molecular Sequence Data; Nails; Onychomycosis; Sequence Analysis, DNA; Triazoles

2013
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole

2013
Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Antifungal Agents; Antimycin A; Apoptosis; Caspases; Cytochromes c; DNA Fragmentation; DNA, Fungal; Drug Synergism; Electron Transport; Fungal Proteins; Hydroxamic Acids; Itraconazole; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Mitochondria; Reactive Oxygen Species; Rhizopus; Triazoles

2013
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
    Journal of medical economics, 2013, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2013
Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Acetylcysteine; Amphotericin B; Antifungal Agents; Apoptosis; Caspases; Free Radical Scavengers; Hot Temperature; Humans; Itraconazole; Membrane Potentials; Microbial Sensitivity Tests; Phosphatidylserines; Reactive Oxygen Species; Rhizopus; Triazoles

2013
The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis.
    Eukaryotic cell, 2013, Volume: 12, Issue:9

    Topics: Antifungal Agents; Apoptosis; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Itraconazole; Mucorales; Tacrolimus; Triazoles

2013
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2013
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
    World neurosurgery, 2014, Volume: 81, Issue:1

    Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole

2014
Iatrogenic Cushing's syndrome induced by posaconazole.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Androstadienes; Antifungal Agents; Aspergillosis; Bronchi; Bronchodilator Agents; Common Variable Immunodeficiency; Cushing Syndrome; Female; Fluticasone; Humans; Iatrogenic Disease; Itraconazole; Middle Aged; Triazoles

2013
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult

2014
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
    Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult

2014
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole

2014
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
    International journal of medical sciences, 2013, Volume: 10, Issue:12

    Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole

2013
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1

    Topics: Antifungal Agents; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2014
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2014
In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Antifungal Agents; Antiprotozoal Agents; Drug Repositioning; Enzyme Inhibitors; Inhibitory Concentration 50; Itraconazole; Leishmania mexicana; Life Cycle Stages; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Mitochondria; Protozoan Proteins; Sterol 14-Demethylase; Triazoles

2013
Azole-resistant Aspergillus fumigatus in the environment of northern Italy, May 2011 to June 2012.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2014, Mar-27, Volume: 19, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Sentinel Surveillance; Soil Microbiology; Triazoles

2014
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
    Clinical drug investigation, 2014, Volume: 34, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles

2014
Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?
    Environmental monitoring and assessment, 2014, Volume: 186, Issue:9

    Topics: Adaptation, Physiological; Agriculture; Antifungal Agents; Aspergillus; Azoles; Environmental Monitoring; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Portugal; Pyrimidines; Triazoles; Voriconazole; Wine

2014
Madurella mycetomatis is highly susceptible to ravuconazole.
    PLoS neglected tropical diseases, 2014, Volume: 8, Issue:6

    Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Thiazoles; Triazoles

2014
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
    Journal of clinical microbiology, 2014, Volume: 52, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2014
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Molecular Sequence Data; Mutation, Missense; Sequence Analysis, DNA; Triazoles; Voriconazole

2014
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2014, Volume: 88, Issue:4

    Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2014
Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Mycoses, 2014, Volume: 57 Suppl 3

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; DNA, Fungal; Drug Resistance, Fungal; Humans; India; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Mycological Typing Techniques; Nitriles; Pyridines; Rhizopus; Sequence Analysis, DNA; Specimen Handling; Triazoles

2014
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
    Journal of medical economics, 2015, Volume: 18, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid; Mycoses; Triazoles; United States

2015
Calcium signaling mediates antifungal activity of triazole drugs in the Aspergilli.
    Fungal genetics and biology : FG & B, 2015, Volume: 81

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Aspergillus nidulans; Calcium Chelating Agents; Calcium Signaling; Culture Media; Disease Models, Animal; Egtazic Acid; Gene Expression Profiling; Invasive Pulmonary Aspergillosis; Itraconazole; Lepidoptera; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles

2015
Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Triazoles

2015
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:6

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles

2015
[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
    Medical mycology journal, 2014, Volume: 55, Issue:4

    Topics: Antifungal Agents; Arthrodermataceae; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Itraconazole; Naphthalenes; Terbinafine; Thiazoles; Triazoles

2014
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
    Mycoses, 2015, Volume: 58, Issue:5

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole

2015
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
    Mycoses, 2015, Volume: 58, Issue:6

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole

2015
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
    PLoS pathogens, 2015, Volume: 11, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole

2015
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole

2015
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:8

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult

2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole

2015
Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles

2015
Reply to Wong et al.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles

2015
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
    Clinical therapeutics, 2015, Volume: 37, Issue:9

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles

2015
Electrochemical behavior of the antifungal agents itraconazole, posaconazole and ketoconazole at a glassy carbon electrode.
    Die Pharmazie, 2015, Volume: 70, Issue:6

    Topics: Antifungal Agents; Carbon; Electrochemical Techniques; Electrochemistry; Electrodes; Indicators and Reagents; Itraconazole; Ketoconazole; Solutions; Triazoles

2015
Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: 14-alpha Demethylase Inhibitors; Animals; Culture Media; Drug Synergism; Drug Therapy, Combination; Ergosterol; Farnesyl-Diphosphate Farnesyltransferase; Humans; Itraconazole; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Lipid Droplets; Membrane Potential, Mitochondrial; Mice; Mitochondria; Parasitic Sensitivity Tests; Pyridines; Quinuclidines; Reactive Oxygen Species; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents

2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
    Journal of medical economics, 2016, Volume: 19, Issue:1

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles

2016
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Comparative immunology, microbiology and infectious diseases, 2015, Volume: 42

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2015
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole

2015
Triazole Susceptibilities in Thermotolerant Fungal Isolates from Outdoor Air in the Seoul Capital Area in South Korea.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Air Microbiology; Antifungal Agents; Aspergillus; DNA, Fungal; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Paecilomyces; Republic of Korea; Sequence Analysis, DNA; Triazoles

2015
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole

2016
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole

2016
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole

2016
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole

2016
A combination approach to treating fungal infections.
    Scientific reports, 2015, Nov-23, Volume: 5

    Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole

2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
    Mycoses, 2016, Volume: 59, Issue:5

    Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole

2016
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Mycoses, 2016, Volume: 59, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
    Journal de mycologie medicale, 2016, Volume: 26, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole

2016
Onychomycosis: Strategies to Minimize Recurrence.
    Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles

2016
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole

2016
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole

2016
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Antifungal Agents; Drug Interactions; Hospitalization; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.
    Annals of hematology, 2016, Volume: 95, Issue:6

    Topics: Aged; Antifungal Agents; Cohort Studies; Drug Delivery Systems; Empirical Research; Febrile Neutropenia; Female; Humans; Itraconazole; Male; Middle Aged; Post-Exposure Prophylaxis; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles

2016
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole

2016
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States

2016
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
    Mycoses, 2016, Volume: 59, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2016
Fungal infection of cystic fibrosis patients - single center experience.
    Pneumonologia i alergologia polska, 2016, Volume: 84, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts

2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult

2016
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
    ChemMedChem, 2016, 07-19, Volume: 11, Issue:14

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole

2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
    Mycoses, 2017, Volume: 60, Issue:2

    Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole

2017
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
    BMC infectious diseases, 2016, 09-02, Volume: 16

    Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult

2016
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:12

    Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult

2016
In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT.
    International journal of pharmaceutics, 2016, Dec-30, Volume: 515, Issue:1-2

    Topics: Capsules; Duodenum; Fasting; Gastric Mucosa; Gastrointestinal Transit; Humans; Intestinal Absorption; Itraconazole; Phenobarbital; Solubility; Triazoles

2016
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole

2017
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
    Clinical chemistry and laboratory medicine, 2017, May-01, Volume: 55, Issue:6

    Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole

2017
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
    Mycoses, 2017, Volume: 60, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole

2017
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-03, Volume: 114, Issue:1

    Topics: Androstenes; Animals; Antifungal Agents; Binding Sites; Biological Transport; Carrier Proteins; Cell Line; CHO Cells; Cholesterol; Cricetulus; Endocytosis; Itraconazole; Ketoconazole; Lysosomes; Membrane Glycoproteins; Protein Binding; Protein Domains; Triazoles

2017
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole.
    Biochemical pharmacology, 2017, 04-15, Volume: 130

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Antifungal Agents; Enzyme Inhibitors; HEK293 Cells; Humans; Itraconazole; Rats; Structure-Activity Relationship; Triazoles

2017
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
    Veterinary dermatology, 2017, Volume: 28, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; Ketoconazole; Malaysia; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles

2017
Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients.
    Mycoses, 2017, Volume: 60, Issue:6

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Intestine, Small; Itraconazole; Lipopeptides; Male; Multilocus Sequence Typing; Sequence Analysis, DNA; Transplant Recipients; Triazoles; Young Adult

2017
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.
    Therapeutic drug monitoring, 2017, Volume: 39, Issue:2

    Topics: Antifungal Agents; Azoles; Drug Monitoring; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Plasma; Retrospective Studies; Tablets; Transplant Recipients; Triazoles; Voriconazole

2017
Triazole Resistance in
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles; Voriconazole

2017
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole

2017
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
    Memorias do Instituto Oswaldo Cruz, 2017, Volume: 112, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Terbinafine; Triazoles

2017
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9

    Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2017
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
    Mycoses, 2017, Volume: 60, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole

2017
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Therapeutic drug monitoring, 2017, Volume: 39, Issue:5

    Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2017
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
    Advances in therapy, 2017, Volume: 34, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles

2017
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
    Mycopathologia, 2017, Volume: 182, Issue:11-12

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole

2017
A Comparative Study on the Performance of Inert and Functionalized Spheres Coated with Solid Dispersions Made of Two Structurally Related Antifungal Drugs.
    Molecular pharmaceutics, 2017, 11-06, Volume: 14, Issue:11

    Topics: Antifungal Agents; Cellulose; Itraconazole; Tartrates; Triazoles

2017
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole

2017
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole

2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
    Mycoses, 2018, Volume: 61, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles

2018
Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae).
    Antiviral research, 2018, Volume: 149

    Topics: Animals; Antifungal Agents; Antiviral Agents; Cell Line; Cells, Cultured; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Humans; Itraconazole; Parechovirus; Picornaviridae Infections; Triazoles

2018
Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
    Acta biochimica Polonica, 2017, Volume: 64, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Genetic; Triazoles; Voriconazole

2017
Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice.
    Medical mycology, 2018, Aug-01, Volume: 56, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disease Models, Animal; Drug Resistance, Fungal; Female; Humans; Itraconazole; Lymphocyte Count; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Spleen; Treatment Outcome; Triazoles; Virulence

2018
The artificial membrane insert system as predictive tool for formulation performance evaluation.
    International journal of pharmaceutics, 2018, Feb-15, Volume: 537, Issue:1-2

    Topics: Chemistry, Pharmaceutical; Cyclodextrins; Intestinal Absorption; Itraconazole; Membranes, Artificial; Nanoparticles; Particle Size; Permeability; Pharmaceutical Preparations; Solubility; Suspensions; Triazoles

2018
Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:4

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Triazoles

2018
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole

2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:6

    Topics: Adult; Asian People; Computer Simulation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Genotype; Glucuronosyltransferase; Humans; Itraconazole; Male; Middle Aged; Models, Biological; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Pyridines; Risk Factors; Substrate Specificity; Triazoles; White People; Young Adult

2018
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
    Mycoses, 2018, Volume: 61, Issue:7

    Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Sequence Analysis, DNA; Soil Microbiology; Sporothrix; Sporotrichosis; Triazoles

2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2018
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2018
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7

    Topics: Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate.
    Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1

    Topics: Antifungal Agents; Azoles; Chromatography, High Pressure Liquid; Humans; Itraconazole; Serum; Triazoles; Voriconazole

2018
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein.
    Antiviral research, 2018, Volume: 157

    Topics: Animals; Antifungal Agents; Antiviral Agents; Chlorocebus aethiops; Dengue Virus; Drug Repositioning; HeLa Cells; Humans; Itraconazole; Receptors, Steroid; Triazoles; Vero Cells; Virus Replication; Zika Virus

2018
Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2018, Volume: 130

    Topics: Antifungal Agents; Chemistry, Pharmaceutical; Crystallization; Dynamic Light Scattering; Excipients; Itraconazole; Ketoconazole; Nanoparticles; Particle Size; Polyethylene Glycols; Solvents; Technology, Pharmaceutical; Triazoles

2018
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole

2018
Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:11

    Topics: Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Catalytic Domain; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Protein Binding; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles

2018
Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
    Life sciences, 2019, Jan-15, Volume: 217

    Topics: Binding Sites; Hedgehog Proteins; Humans; Itraconazole; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Domains; Signal Transduction; Smoothened Receptor; Thermodynamics; Triazoles

2019
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
    AAPS PharmSciTech, 2019, Jan-02, Volume: 20, Issue:1

    Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole

2019
Novel Point Mutations in
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:5

    Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Binding Sites; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Nails; Point Mutation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Sequence Alignment; Sputum; Structural Homology, Protein; Triazoles

2019
The Evolution of Azole Resistance in
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole

2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019
Why do lung transplant patients discontinue triazole prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole

2019
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.
    Emerging microbes & infections, 2019, Volume: 8, Issue:1

    Topics: A549 Cells; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Human Umbilical Vein Endothelial Cells; Humans; Influenza A virus; Itraconazole; Mice; Mortality; Orthomyxoviridae Infections; Triazoles; Vero Cells; Viral Load; Virus Replication

2019
Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.
    Journal of medicinal chemistry, 2019, 04-25, Volume: 62, Issue:8

    Topics: Animals; Binding Sites; Cell Line; Cell Proliferation; Drug Design; Hedgehog Proteins; Humans; Itraconazole; Mice; Molecular Dynamics Simulation; Signal Transduction; Structure-Activity Relationship; Triazoles

2019
A Revised Species Concept for Opportunistic
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucormycosis; Natamycin; Nitriles; Pyridines; Rhizopus; Species Specificity; Terbinafine; Triazoles

2019
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2020, Volume: 50, Issue:3

    Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole

2020
High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
    Medical mycology, 2020, Feb-01, Volume: 58, Issue:2

    Topics: Animals; Antifungal Agents; Azoles; Dermatomycoses; Dog Diseases; Dogs; Drug Resistance, Multiple, Fungal; Itraconazole; Japan; Malassezia; Microbial Sensitivity Tests; Thiazoles; Triazoles

2020
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2019
Evaluation of the Gradient Concentration Strip Method for Antifungal Susceptibility Testing of Isavuconazole and Comparators for
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucorales; Nitriles; Pyridines; Triazoles

2019
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
    Acta dermatovenerologica Croatica : ADC, 2019, Volume: 27, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles

2019
    Journal of medical microbiology, 2019, Volume: 68, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
    Medical mycology, 2020, Jul-01, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2020
Inhibition of hedgehog signaling by stereochemically defined des-triazole itraconazole analogues.
    Bioorganic & medicinal chemistry letters, 2020, 01-15, Volume: 30, Issue:2

    Topics: Hedgehog Proteins; Humans; Inhibitory Concentration 50; Itraconazole; Signal Transduction; Structure-Activity Relationship; Triazoles

2020
In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.
    Medical mycology, 2020, Aug-01, Volume: 58, Issue:6

    Topics: Humans; Infections; Itraconazole; Microbial Sensitivity Tests; Prototheca; Thiazoles; Triazoles

2020
The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics.
    International journal of pharmaceutics, 2020, Jan-05, Volume: 573

    Topics: Administration, Oral; Antifungal Agents; Antiviral Agents; Biological Availability; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Liberation; Equivalence Trials as Topic; Itraconazole; Nitriles; Particle Size; Pyridazines; Pyrimidines; Research Design; Ritonavir; Solubility; Therapeutic Equivalency; Triazoles; X-Ray Diffraction

2020
Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
    FEMS microbiology letters, 2019, 11-01, Volume: 366, Issue:21

    Topics: Agriculture; Antifungal Agents; Environmental Exposure; Environmental Microbiology; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Mycoses; Phylogeny; Triazoles; Trichoderma

2019
Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle.
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Animals; Antifungal Agents; Antiviral Agents; Enterovirus; Itraconazole; Parechovirus; Triazoles

2020
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2020
In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
    Japanese journal of infectious diseases, 2020, May-22, Volume: 73, Issue:3

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Thiazoles; Triazoles

2020
Subcutaneous Trichophyton rubrum abscesses in an immunocompromised patient.
    The Journal of dermatology, 2020, Volume: 47, Issue:3

    Topics: Abscess; Aged; Antifungal Agents; Arthrodermataceae; Female; Humans; Immunocompromised Host; Itraconazole; Triazoles

2020
Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles

2020
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
    The Journal of steroid biochemistry and molecular biology, 2020, Volume: 199

    Topics: Aldosterone; Animals; Antifungal Agents; Azoles; Cricetinae; Disease Models, Animal; Drug Monitoring; HEK293 Cells; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Hypothalamo-Hypophyseal System; Itraconazole; Mineralocorticoids; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Triazoles

2020
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
    BMC microbiology, 2020, 02-07, Volume: 20, Issue:1

    Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat

2020
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole

2020
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    JAMA dermatology, 2020, 07-01, Volume: 156, Issue:7

    Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole

2020
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2021, Volume: 52, Issue:1

    Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles

2021
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
    Mycoses, 2021, Volume: 64, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2021
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
    Current drug metabolism, 2020, Volume: 21, Issue:13

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole

2020
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Molecular biology reports, 2020, Volume: 47, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole

2020
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
    Toxicology and applied pharmacology, 2021, 02-01, Volume: 412

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Itraconazole; Mineralocorticoid Excess Syndrome, Apparent; Protein Conformation; Species Specificity; Structure-Activity Relationship; Triazoles; Zebrafish Proteins

2021
Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum.
    Mycopathologia, 2021, Volume: 186, Issue:1

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Reproducibility of Results; Triazoles; Voriconazole

2021
The Triazole Ring as a Privileged Scaffold for Putative Antifungals: Synthesis and Evaluation of a Series of New Analogues.
    ChemMedChem, 2021, 01-08, Volume: 16, Issue:1

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Itraconazole; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Triazoles

2021
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
    Mycoses, 2021, Volume: 64, Issue:10

    Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Ergosterol; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole; Whole Genome Sequencing

2021
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole

2021
Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan.
    Clinical and translational science, 2021, Volume: 14, Issue:6

    Topics: Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Indoles; Itraconazole; Pyridines; Pyrrolidines; Risk Assessment; Triazoles

2021
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations.
    Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:4

    Topics: Antifungal Agents; Critical Illness; Humans; Itraconazole; Lung; Retrospective Studies; Transplant Recipients; Triazoles

2021
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
    Antimicrobial agents and chemotherapy, 2021, 08-17, Volume: 65, Issue:9

    Topics: Antifungal Agents; Disk Diffusion Antimicrobial Tests; Itraconazole; Madurella; Microbial Sensitivity Tests; Triazoles; Voriconazole

2021
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.
    Biotechnology progress, 2022, Volume: 38, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Itraconazole; Microbial Sensitivity Tests; Nanoparticles; Selenium; Triazoles; Voriconazole

2022
In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Molecular pharmaceutics, 2021, 11-01, Volume: 18, Issue:11

    Topics: 4-Aminobenzoic Acid; Adjuvants, Pharmaceutic; Administration, Oral; Animals; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Liberation; Gastrointestinal Absorption; Itraconazole; Ketoconazole; Male; Rats; Solubility; Triazoles

2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Antifungal Agents; Aspergillus fumigatus; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; France; Fungal Proteins; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Respiratory Tract Infections; Retrospective Studies; Triazoles; Tubulin; Voriconazole

2021
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates.
    Mycoses, 2022, Volume: 65, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Triazoles

2022
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:6

    Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole

2022
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Candida albicans; Drug Resistance, Fungal; Exophiala; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Morpholines; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Voriconazole

2022
Itraconazole and Voriconazole: The Complexity of Dose Adjustments.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-31, Volume: 75, Issue:3

    Topics: Antifungal Agents; Humans; Itraconazole; Triazoles; Voriconazole

2022
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Mycoses, 2022, Volume: 65, Issue:6

    Topics: Antifungal Agents; Humans; Imidazoles; Itraconazole; Madurella; Mycetoma; Thiazoles; Triazoles

2022
Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Mycoses, 2022, Volume: 65, Issue:12

    Topics: Antifungal Agents; Humans; Itraconazole; Madurella; Mycetoma; Triazoles

2022
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:3

    Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
    Annals of clinical microbiology and antimicrobials, 2023, Feb-20, Volume: 22, Issue:1

    Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles

2023
In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
    Journal de mycologie medicale, 2023, Volume: 33, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Auranofin; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
Succinylation modification provides new insights for the treatment of immunocompromised individuals with drug-resistant
    Frontiers in immunology, 2023, Volume: 14

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Lysine; Mice; Triazoles

2023
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
    Medical mycology, 2023, Aug-02, Volume: 61, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole

2023
Disseminated histoplasmosis in an immunosuppressed patient successfully treated with isavuconazole.
    BMJ case reports, 2023, Aug-18, Volume: 16, Issue:8

    Topics: Histoplasmosis; Humans; Itraconazole; Male; Nitriles; Triazoles

2023
HPLC-MS/MS Method Validation for Antifungal Agents in Human Serum in Clinical Application.
    Clinical laboratory, 2023, Sep-01, Volume: 69, Issue:9

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Itraconazole; Tandem Mass Spectrometry; Triazoles; United States; Voriconazole

2023
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Itraconazole; Methanol; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2024